Comparison of young Navy alcohol abusers and drug abusers on demography, personality, performance, and treatment outcome.

1979 ◽  
Author(s):  
Douglas Kolb ◽  
E. K. Gunderson
1983 ◽  
Vol 52 (3) ◽  
pp. 784-786 ◽  
Author(s):  
Patrick Flynn ◽  
Robert C. Mc Mahon

The purpose of this study was to provide data relating to the validity of the Dysthymia and Psychotic Depression scales of the Millon Clinical Mulriaxial Inventory as indicators of serious depression measured by self-report data from che Treatment Outcome Prospective Study (TOPS) survey form. Scores on both Millon scales had low bur staristically significant correlations with TOPS survey items dealing with depression-related physical immobilization and suicidal ideation. Results indicate that these scale had limited value in identifying these significant depression-related symptoms among the 88 drug abusers (M age of 29 yr.)


2010 ◽  
Vol 2010 ◽  
pp. 1-6 ◽  
Author(s):  
Ananda P. Dasanayake ◽  
Saman Warnakulasuriya ◽  
Colin K. Harris ◽  
Derek J. Cooper ◽  
Timothy J. Peters ◽  
...  

Alcohol and drug abuse are detrimental to general and oral health. Though we know the effects of these harmful habits on oral mucosa, their independent and combined effect on the dental caries experience is unknown and worthy of investigation. We compared 363 “alcohol only” abusers to 300 “alcohol and drug” abusers to test the hypothesis that various components of their dental caries experience are significantly different due to plausible sociobiological explanations. After controlling for the potential confounders, we observe that the “alcohol and drug” group had a 38% higher risk of having decayed teeth compared to the “alcohol only” group (). As expected, those who belonged to a higher social class (; 95%  –2.75) and drank wine (; 95%  –2.96) had a higher risk of having more filled teeth. We conclude that the risk of tooth decay among “alcohol only” abusers is significantly lower compared to “alcohol and drug” abusers.


2002 ◽  
Vol 68 (3) ◽  
pp. 237-243 ◽  
Author(s):  
W.Miles Cox ◽  
Lee M Hogan ◽  
Marc R Kristian ◽  
Julian H Race

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Anni Lehikoinen ◽  
Raimo Voutilainen ◽  
Jarkko Romppanen ◽  
Seppo Heinonen

Abstract Background The purpose of this study was to determine whether first trimester trisomy screening (FTS) parameters are affected by alcohol and drug use. Methods A routine combined FTS including measurements of maternal serum levels of free β-human chorionic gonadotropin subunit (free β-hCG) and pregnancy-associated plasma protein A (PAPP-A) were measured at 9–11 weeks of gestation, and fetal nuchal translucency thickness (NTT) at 11–13 weeks of gestation. In total 544 women with singleton pregnancies [71 alcohol and drug abusers, 88 smokers, 168 non-smokers delivering a small for gestational age (SGA) child, and 217 unexposed control women] were assessed. Results Free β-hCG levels were higher in alcohol and drug abusing than in unexposed pregnant women [mean 1.5 vs. 1.2 multiples of medians (MoM); P = 0.013]. However, stepwise multiple linear regression analyses suggested that smoking could explain increased free β-hCG. Additionally, we observed lower PAPP-A levels in the smoking mothers (0.9 vs. 1.2 MoM; P = 0.045) and in those giving birth to an SGA child compared to the controls (1.1 vs.. 1.2 MoM; P < 0.001). Fetal NTT did not differ significantly between any of the groups. Conclusions The present study shows increased free β-hCG levels in alcohol and drug abusers, but maternal smoking may explain the result. Maternal serum PAPP-A levels were lower in smoking than non-smoking mothers, and in mothers delivering an SGA child. However, FTS parameters (PAPP-A, free β-hCG and NTT) seem not to be applicable for the use as alcohol biomarkers because of their clear overlap between alcohol abusers and healthy controls.


2009 ◽  
Vol 26 (4) ◽  
pp. 339-353 ◽  
Author(s):  
Johan Edman

Aims The aim of this article is to investigate the use of a rather vague medical conceptual framework within the compulsory treatment of alcohol and drug users in Sweden during the 20th century. The focus lies on exploring how a phenomenon came to be described as pathological, what the causes are for certain actions being suddenly interpreted in medical terms, and what consequences that might lead to. Design Supported by theoretical speculations on medicalization processes and conceptual history, two empirical cases (the compulsory care of alcohol abusers in the 1950s and the legislative process leading to psychiatric compulsory care of drug users in the late 1960s) are investigated. The first case draws mainly upon official reports and archive material from alcohol treatment institutions, whilst the second case is built from reading official reports and parliamentary material. The research task for the two empirical cases has not quite been the same: whereas the first case is illustrated by the discrepancies between the labelling of treatment activities and the treatment actually carried out, the second case rather draws upon the enlargement of the field of signification of the disease concept to cover most aspects of drug use. Results A medicalization process on different levels is traced both in the post-war compulsory treatment of alcohol abusers as well as the compulsory psychiatric care for drug abusers that was introduced from the late 1960s onwards. Conclusion The investigated cases show how the medicalization processes benefited from conceptual vagueness, leading to a widening of the conceptual dimensions of both the treatment and disease concepts. In this, the medicalization of alcohol abuse in the 1950s and drug abuse in the 1960s made way for a paternalistic justification of compulsory care measures that might otherwise have become politically troublesome.


Neurology ◽  
2017 ◽  
Vol 88 (9) ◽  
pp. 909-915 ◽  
Author(s):  
Jordan L. Schultz ◽  
John A. Kamholz ◽  
David J. Moser ◽  
Shawna M.E. Feely ◽  
Jane S. Paulsen ◽  
...  

Objective:To investigate the relationship between substances of abuse and age at motor onset (AMO) in patients with Huntington disease (HD) in a large and diverse patient population.Methods:This was a retrospective, observational study of the Enroll-HD database. Participants were determined to belong to 1 of 3 substance abuse groups: (1) tobacco abusers, (2) alcohol abusers, and (3) drug abusers. A group of participants who had never abused substances served as a control group. The average AMO of patients in the substance abuse groups was compared to the control group. The number of CAG repeats was used as a covariate in all analyses.Results:The average difference in AMOs of participants in the tobacco (n = 566), alcohol (n = 374), and drug abuse groups (n = 217) compared to the control group (n = 692) were 2.3 (F1, 1,258 = 33.8, p < 0.0001), 1.0 (F1, 1,066 = 4.2, p = 0.04), and 3.3 (F1, 909 = 29.7, p < 0.0001) years earlier, respectively. In all substance abuse groups, the AMO was lowered to a greater degree in female participants than it was in male participants.Conclusions:Substances of abuse have a strong effect on the AMO in patients with HD. These effects seem to be amplified in women with HD compared to men. These results may provide a safe intervention capable of adding disease-free years to patients with HD.


Sign in / Sign up

Export Citation Format

Share Document